Paper Details

  1. Home
  2. Paper Details

Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.

Author: BrigoFrancesco, LattanziSimona, RocchiChiara, SalveminiSergio, SilvestriniMauro, StrianoPasquale, TrinkaEugen

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This study describes the use of cannabidiol (CBD) for the treatment of seizures associated with Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex.
Paper Details　
Original Abstract of the Article :
Cannabidiol (CBD), which is one major constituent of the Cannabis sativa plant, has anti-seizure properties and does not produce euphoric or intrusive side effects. A plant-derived, highly purified CBD formulation with a known and constant composition has been approved by the US Food and Drug Admini...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005394/

データ提供：米国国立医学図書館（NLM）

Beyond Dravet and Lennox-Gastaut: Cannabidiol for Epilepsy Treatment

Epilepsy, a neurological disorder characterized by recurrent seizures, can have a profound impact on patients' lives. This study examines the potential of highly purified cannabidiol (CBD), a non-psychoactive compound derived from the Cannabis sativa plant, for treating various epileptic conditions. The researchers provide a comprehensive review of the literature on CBD's efficacy in treating seizures associated with Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex. They conclude that CBD, with its anti-seizure properties and minimal side effects, holds significant promise for treating a range of epileptic conditions.

CBD: A Promising New Frontier in Epilepsy Treatment

This systematic review highlights the potential of CBD as a valuable treatment option for epilepsy. The evidence suggests that CBD, with its anti-seizure properties and favorable side effect profile, holds promise for treating a range of epileptic conditions, including Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex. This opens up new avenues for developing more effective and tolerable treatment options for epilepsy patients.

Exploring the Benefits of Cannabidiol for Epilepsy

The study emphasizes the growing body of evidence supporting the use of CBD for treating epilepsy. This research provides a valuable resource for healthcare professionals and patients seeking information about CBD's potential benefits in managing epileptic seizures.

Dr.Camel's Conclusion

Imagine a desert landscape, where epilepsy, like a sandstorm, disrupts the peace and tranquility. CBD, like a calming oasis, offers a safe haven, reducing the intensity and frequency of the sandstorms. This systematic review explores the potential of CBD as a powerful tool for managing epilepsy, providing hope for those affected by this challenging neurological disorder.

Date :
  1. Date Completed 2022-01-10
  2. Date Revised 2022-01-10
Further Info :

Pubmed ID

33754312

DOI: Digital Object Identifier

PMC8005394

Related Literature

Article Analysis
・Side Effects of clobazam
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.